These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 8018371)

  • 21. Continuous hyperfractionated accelerated radiotherapy with/without mitomycin C in head and neck cancers.
    Dobrowsky W; Naudé J
    Radiother Oncol; 2000 Nov; 57(2):119-24. PubMed ID: 11054514
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Altered fractionation: limited by mucosal reactions?
    Kaanders JH; van der Kogel AJ; Ang KK
    Radiother Oncol; 1999 Mar; 50(3):247-60. PubMed ID: 10392810
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Accelerated fractionation radiotherapy for laryngeal cancer, acute, and late toxicity.
    Kaanders JH; van Daal WA; Hoogenraad WJ; van der Kogel AJ
    Int J Radiat Oncol Biol Phys; 1992; 24(3):497-503. PubMed ID: 1399736
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Radiation-free weekend rescued! Continuous accelerated irradiation of 7-days per week is equal to accelerated fractionation with concomitant boost of 7 fractions in 5-days per week: report on phase 3 clinical trial in head-and-neck cancer patients.
    Skladowski K; Hutnik M; Wygoda A; Golen M; Pilecki B; Przeorek W; Rutkowski T; Lukaszczyk-Widel B; Heyda A; Suwinski R; Tarnawski R; Maciejewski B
    Int J Radiat Oncol Biol Phys; 2013 Mar; 85(3):741-6. PubMed ID: 22836063
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Accelerated fractionation (AF) compared to conventional fractionation (CF) improves loco-regional control in the radiotherapy of advanced head and neck cancers: results of the EORTC 22851 randomized trial.
    Horiot JC; Bontemps P; van den Bogaert W; Le Fur R; van den Weijngaert D; Bolla M; Bernier J; Lusinchi A; Stuschke M; Lopez-Torrecilla J; Begg AC; Pierart M; Collette L
    Radiother Oncol; 1997 Aug; 44(2):111-21. PubMed ID: 9288839
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Is there an optimum overall time for head and neck radiotherapy? A review, with new modelling.
    Fowler JF
    Clin Oncol (R Coll Radiol); 2007 Feb; 19(1):8-22. PubMed ID: 17305251
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The feasibility of high-dose multiple daily fractionation and its combination with anoxic cell sensitizers in the treatment of head and neck cancer. A pilot study of the Radiotherapy Group of the EORTC (European Organisation for Research on Treatment of Cancer).
    Van den Bogaert W; van der Schueren E; Horiot JC; Chaplain G; Arcangeli G; Gonzalez D; Svoboda V
    Int J Radiat Oncol Biol Phys; 1982 Oct; 8(10):1649-55. PubMed ID: 7153077
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Evaluation of mucosal acute radiation injury during accelerated-hyperfractionted split course radiotherapy (CHA-CHA) in advanced head and neck neoplasms].
    Miszczyk L; Tarnawski R; Woźniak G; Maciejewski B
    Otolaryngol Pol; 2002; 56(5):543-9. PubMed ID: 12523161
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Feasibility and outcome of a progressively accelerated concomitant boost radiotherapy schedule for head and neck carcinomas.
    Allal AS; Bieri S; Miralbell R; Marchal F; Lehmann W; Kurtz JM
    Int J Radiat Oncol Biol Phys; 1997 Jul; 38(4):685-9. PubMed ID: 9240633
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preliminary report of pulsed dose rate brachytherapy in head-and-neck cancer.
    Ziemlewski A; Zienkiewicz J; Serkies K; Badzio A
    Strahlenther Onkol; 2007 Sep; 183(9):512-6. PubMed ID: 17762926
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hypofractionated radiotherapy denoted as the "Christie scheme": an effective means of palliating patients with head and neck cancers not suitable for curative treatment.
    Al-mamgani A; Tans L; Van rooij PH; Noever I; Baatenburg de jong RJ; Levendag PC
    Acta Oncol; 2009; 48(4):562-70. PubMed ID: 19373698
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of late complications after rapid hyperfractionated radiotherapy in advanced head and neck cancers.
    Nguyen TD; Panis X; Froissart D; Legros M; Coninx P; Loirette M
    Int J Radiat Oncol Biol Phys; 1988 Jan; 14(1):23-5. PubMed ID: 3335458
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Altered fractionation trials in head and neck cancer.
    Ang KK
    Semin Radiat Oncol; 1998 Oct; 8(4):230-6. PubMed ID: 9873100
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A randomised multicentre trial of CHART versus conventional radiotherapy in head and neck cancer.
    Dische S; Saunders M; Barrett A; Harvey A; Gibson D; Parmar M
    Radiother Oncol; 1997 Aug; 44(2):123-36. PubMed ID: 9288840
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The potential for sparing of parotids and escalation of biologically effective dose with intensity-modulated radiation treatments of head and neck cancers: a treatment design study.
    Wu Q; Manning M; Schmidt-Ullrich R; Mohan R
    Int J Radiat Oncol Biol Phys; 2000 Jan; 46(1):195-205. PubMed ID: 10656393
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Randomized clinical trial on 7-day-continuous accelerated irradiation (CAIR) of head and neck cancer - report on 3-year tumour control and normal tissue toxicity.
    Skladowski K; Maciejewski B; Golen M; Pilecki B; Przeorek W; Tarnawski R
    Radiother Oncol; 2000 May; 55(2):101-10. PubMed ID: 10799721
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Late effects of hyperfractionated radiotherapy for advanced head and neck cancer: long-term follow-up results of RTOG 83-13.
    Fu KK; Pajak TF; Marcial VA; Ortiz HG; Rotman M; Asbell SO; Coia LR; Vora NL; Byhardt R; Rubin P
    Int J Radiat Oncol Biol Phys; 1995 Jun; 32(3):577-88. PubMed ID: 7790242
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Radiotherapy by multiple fractions per day (MFD) in head and neck cancer: acute reactions of skin and mucosa.
    Van der Schueren E; Van den Bogaert W; Vanuytsel L; Van Limbergen E
    Int J Radiat Oncol Biol Phys; 1990 Aug; 19(2):301-11. PubMed ID: 2394609
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sensitivity analysis of parameters in linear-quadratic radiobiologic modeling.
    Fowler JF
    Int J Radiat Oncol Biol Phys; 2009 Apr; 73(5):1532-7. PubMed ID: 19306749
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acute toxicity of curative radiotherapy in elderly patients.
    Huguenin P; Glanzmann C; Lütolf UM
    Strahlenther Onkol; 1996 Dec; 172(12):658-63. PubMed ID: 8972750
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.